Grand Challenges in Oncology

por Giaccone, Giuseppe
Publicado 2011

In Memory of Professor John Gordon McVie: Bringing People Together 13 January 1945 – 20 January 2021

por Giaccone, Giuseppe
Publicado 2021

Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report

por Voortman, Jens, Giaccone, Giuseppe
Publicado 2006

Challenges in Cancer Molecular Targets and Therapeutics

por Wang, Yisong, Giaccone, Giuseppe
Publicado 2011

Amivantamab in the Treatment of Metastatic NSCLC: Patient Selection and Special Considerations

por Petrini, Iacopo, Giaccone, Giuseppe
Publicado 2022

Challenges in Diversity, Equity, and Inclusion in Research and Clinical Oncology

por El-Deiry, Wafik S., Giaccone, Giuseppe
Publicado 2021

Best practices and guidelines for the management of thymic epithelial tumors

por Giaccone, Giuseppe, Lischalk, Jonathan W.
Publicado 2019

The proteasomal and apoptotic phenotype determine bortezomib sensitivity of non-small cell lung cancer cells

por Voortman, Jens, Chęcińska, Agnieszka, Giaccone, Giuseppe
Publicado 2007

Novel Treatments for Thymoma and Thymic Carcinoma

por Rajan, Arun, Wakelee, Heather, Giaccone, Giuseppe
Publicado 2015

Clinical evaluation of dacomitinib for the treatment of metastatic non-small cell lung cancer (NSCLC): current perspectives

por Lavacchi, Daniele, Mazzoni, Francesca, Giaccone, Giuseppe
Publicado 2019

Plantar erythrodysesthesia with bullous otitis externa, toxicities from sorafenib: a case report

por Carter, Corey A, Rajan, Arun, Giaccone, Giuseppe
Publicado 2009

Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States

por Thomas, Anish, Chen, Yuanbin, Yu, Tinghui, Jakopovic, Marko, Giaccone, Giuseppe
Publicado 2015

Molecular predictors of response to pembrolizumab in thymic carcinoma

por He, Yongfeng, Ramesh, Archana, Gusev, Yuriy, Bhuvaneshwar, Krithika, Giaccone, Giuseppe
Publicado 2021

Functional analysis of cancer-associated EGFR mutants using a cellular assay with YFP-tagged EGFR intracellular domain

por de Gunst, Matheus M, Gallegos-Ruiz, Marielle I, Giaccone, Giuseppe, Rodriguez, Jose Antonio
Publicado 2007

Prediction of outcome of non-small cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling

por Voortman, Johannes, Pham, Thang V, Knol, Jaco C, Giaccone, Giuseppe, Jimenez, Connie R
Publicado 2009

Targeting the Epigenome in Lung Cancer: Expanding Approaches to Epigenetic Therapy

por Jakopovic, Marko, Thomas, Anish, Balasubramaniam, Sanjeeve, Schrump, David, Giaccone, Giuseppe, Bates, Susan E.
Publicado 2013

CRKL mediates EML4-ALK signaling and is a potential therapeutic target for ALK-rearranged lung adenocarcinoma

por An, Rong, Wang, Yisong, Voeller, Donna, Gower, Arjan, Kim, In-Kyu, Zhang, Yu-Wen, Giaccone, Giuseppe
Publicado 2016

EGFR and K-ras Mutation Analysis in Non-Small Cell Lung Cancer: Comparison of Paraffin Embedded versus Frozen Specimens

por Gallegos Ruiz, Mariëlle I., Floor, Karijn, Rijmen, Frank, Grünberg, Katrien, Rodriguez, José A, Giaccone, Giuseppe
Publicado 2007

A Phase Ib/II Study of Ganetespib With Doxorubicin in Advanced Solid Tumors Including Relapsed-Refractory Small Cell Lung Cancer

por Subramaniam, Deepa S., Liu, Stephen V., Crawford, Jeanette, Kramer, Jenna, Thompson, Jillian, Wang, Hongkun, Giaccone, Giuseppe
Publicado 2018

Publication Rate and Characteristics of Lung Cancer Clinical Trials

por Al-Shbool, Ghassan, Latif, Hira, Farid, Saira, Wang, Shuqi, Ahn, Jaeil, Giaccone, Giuseppe, Kim, Chul
Publicado 2019